4.0 Review

There is no benefit in the use of postnatal intravenous immunoglobulin for the prevention of relapses of multiple sclerosis: findings from a systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

Multiple sclerosis: Pathology, diagnosis and treatments

Wen-Juan Huang et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)

Article Obstetrics & Gynecology

The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis

Evelyn Brandt-Wouters et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2016)

Article Clinical Neurology

Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis

Sandra Vukusic et al.

MULTIPLE SCLEROSIS JOURNAL (2015)

Article Public, Environmental & Occupational Health

Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother

Yara Dadalti Fragoso et al.

HEALTH CARE FOR WOMEN INTERNATIONAL (2015)

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Review Health Care Sciences & Services

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)

Article Clinical Neurology

Immunomodulation and postpartum relapses in patients with multiple sclerosis

Kerstin Hellwig et al.

Therapeutic Advances in Neurological Disorders (2009)

Article Clinical Neurology

Reproductive counselling, treatment and course of pregnancy in 73 German MS patients

K. Hellwig et al.

ACTA NEUROLOGICA SCANDINAVICA (2008)

Article Clinical Neurology

A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis

Judith Haas et al.

MULTIPLE SCLEROSIS JOURNAL (2007)

Article Clinical Neurology

Immunoglobulin treatment of multiple sclerosis: future prospects

L Durelli et al.

NEUROLOGICAL SCIENCES (2003)